Invitation to presentation of the Q2 report 2023
STOCKHOLM – August 3 2023 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, will publish the report for the first quarter 2023 at 08:00 CET on August 10. Investors, financial analysts, and media are invited to participate in a webcast and a following Q&A session on August 10 at 09:00 CET.
The presentation will be hosted by Monica Shaw, CEO, together with Holger Lembrér, CFO and Sofia Heigis, CCO. It will be held in English. It will be published on the website of Oncopeptides in conjunction with the start of the presentation.
Information for participants
If you wish to participate via webcast please use the link below. Via the webcast are you able to ask written questions.
If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.